LifeStance Health (LFST) Free Cash Flow (2020 - 2026)

LifeStance Health has disclosed Free Cash Flow across 7 years of filings, most recently posting $22.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 317.76% year-over-year to $22.3 million; the TTM figure through Mar 2026 stood at $142.6 million (up 39.32% YoY), while the FY2025 annual figure was $110.0 million, up 28.39% from the prior year.
• Free Cash Flow slipped to $22.3 million in Q1 2026, from $46.6 million in the prior quarter.
• Over the last five years, Free Cash Flow for LFST reached as high as $56.6 million in Q2 2025 and fell as low as -$35.2 million in Q3 2023.
• The 5-year median for Free Cash Flow is $5.4 million (2023), against an average of $7.9 million.
• Annual changes were most pronounced in 2022 — Free Cash Flow slumped 1999.15% — and 2024, when it jumped 940.98%.
• A 5-year view of Free Cash Flow shows it stood at $25.5 million in 2022, then sank by 78.93% to $5.4 million in 2023, then jumped by 940.98% to $56.0 million in 2024, then slipped by 16.72% to $46.6 million in 2025, then tumbled by 52.11% to $22.3 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $22.3 million, $46.6 million, and $17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.